Dilated heart muscle disease associated with HIV infection
Herskowitz A, Willoughby S, Vlahov D, Baughman K, Ansari A. Dilated heart muscle disease associated with HIV infection. European Heart Journal 1995, 16: 50-55. PMID: 8682102, DOI: 10.1093/eurheartj/16.suppl_o.50.Peer-Reviewed Original ResearchConceptsHeart muscle diseaseLate-stage HIV infectionCD4 T-cell countGlobal left ventricular dysfunctionT-cell countsLeft ventricular dysfunctionHIV infectionRisk factorsVentricular dysfunctionClinical characteristicsCardiac dysfunctionMuscle diseaseNew York Heart Association class IIILow CD4 T-cell countsSevere global left ventricular dysfunctionCell countAnti-heart antibodiesCardiotropic virus infectionImmunologic risk factorsNon-infectious complicationsPrimary cardiac failureSymptomatic cardiac dysfunctionSymptomatic heart diseaseCongestive heart failureHIV risk factorsClinical characteristics and prognostic value of acute retroviral syndrome among injecting drug users
Dorrucci M, Rezza G, Vlahov D, Pezzotti P, Sinicco A, Nicolosi A, Lazzarin A, Galai N, Gafà S, Pristerà R. Clinical characteristics and prognostic value of acute retroviral syndrome among injecting drug users. AIDS 1995, 9: 597-604. PMID: 7662199, DOI: 10.1097/00002030-199506000-00011.Peer-Reviewed Original ResearchConceptsAcute retroviral syndromeHIV infectionHIV seroconvertersRelative hazardDrug usersFirst positive HIV testYear of seroconversionPositive HIV testRate of CD4Kaplan-Meier estimatesCumulative AIDS incidenceAsymptomatic seroconvertersHIV seroconversionClinical characteristicsHIV testClinical progressionPrognostic valueProspective studyClinical centersSeroconvertersCell declineSeroconversionCell countSyndromeNatural history